Achanta LB, Rae CD. ß-Hydroxybutyrate in the brain: One molecule, multiple mechanisms. Neurochem Res. 2017;42(1):35-49. View abstract.
Beylot M, Chassard D, Chambrier C, et al. Metabolic effects of a D-beta-hydroxybutyrate infusion in septic patients: inhibition of lipolysis and glucose production but not leucine oxidation. Crit Care Med. 1994;22(7):1091-8. View abstract.
Clarke K, Tchabanenko K, Pawlosky R, et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol. 2012;63(3):401-8. View abstract.
Cox PJ, Kirk T, Ashmore T, et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab. 2016;24(2):256-68. View abstract.
Evans M, Cogan KE, Egan B. Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation. J Physiol. 2017;595(9):2857-2871. View abstract.
Evans M, Patchett E, Nally R, Kearns R, Larney M, Egan B. Effect of acute ingestion of β-hydroxybutyrate salts on the response to graded exercise in trained cyclists. Eur J Sport Sci. 2018;18(3):376-86. View abstract.
Gautschi M, Weisstanner C, Slotboom J, Nava E, Zürcher T, Nuoffer JM. Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy. Pediatr Res. 2015;77(1-1):91-8. View abstract.
Gross EC, Sandor P, Fischer D. Preliminary data on exogenous ketone bodies in migraine prevention. Cephalalgia 2017; 37(1S) 52-171.
Hashim SA, VanItallie TB. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester. J Lipid Res. 2014;55(9):1818-26. View abstract.
Hiraide A, Katayama M, Sugimoto H, Yoshioka T, Sugimoto T. Effect of 3-hydroxybutyrate on posttraumatic metabolism in man. Surgery. 1991;109(2):176-81. View abstract.
Holdsworth DA, Cox PJ, Kirk T, Stradling H, Impey SG, Clarke K. A ketone ester drink increases postexercise muscle glycogen synthesis in humans. Med Sci Sports Exerc. 2017;49(9):1789-1795. View abstract.
Kawakita T, Uchino M, Fukagawa K, et al. Randomized, multicenter, double-blind study of the safety and efficacy of 1%D-3-hydroxybutyrate eye drops for dry eye disease. Sci Rep. 2016;6:20855. View abstract.
Kemper MF, Srivastava S, Todd King M, Clarke K, Veech RL, Pawlosky RJ. An ester of ß-hydroxybutyrate regulates cholesterol biosynthesis in rats and a cholesterol biomarker in humans. Lipids. 2015;50(12):1185-93. View abstract.
McNally MA, Hartman AL. Ketone bodies in epilepsy. J Neurochem. 2012;121(1):28-35. View abstract.
Newman JC, Verdin E. ß-Hydroxybutyrate: A signaling metabolite. Annu Rev Nutr. 2017;37:51-76. View abstract.
Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL. A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease. Alzheimers Dement. 2015;11(1):99-103. View abstract.
Pawan GL, Semple SJ. Effect of 3-hydroxybutyrate in obese subjects on very-low-energy diets and during therapeutic starvation. Lancet. 1983;1(8314-5):15-7. View abstract.
Plecko B, Stoeckler-Ipsiroglu S, Schober E, et al. Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr Res. 2002;52(2):301-6. View abstract.
Reger MA, Henderson ST, Hale C, et al. Effects of beta-hydroxybutyrate on cognition in
memory-impaired adults. Neurobiol Aging. 2004;25(3):311-4.
View abstract.
Simeone TA, Simeone KA, Stafstrom CE, Rho JM. Do ketone bodies mediate the anti-seizure effects of the ketogenic diet? Neuropharmacology. 2018;133:233-241. View abstract.
Thomsen HH, Rittig N, Johannsen M, et al. Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies. Am J Clin Nutr. 2018;108(4):857-67. View abstract.
Toksoy HB, Tanzer FN, Atalay A. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy. Turk J Pediatr. 1995;37(1):25-9. View abstract.
Valayannopoulos V, Bajolle F, Arnoux JB, et al. Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet. Pediatr Res. 2011;70(6):638-41. View abstrtact.
Van Hove JL, Grünewald S, Jaeken J, et al. D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet. 2003;361(9367):1433-5. View abstract.
Van Rijt WJ, Heiner-Fokkema MR, du Marchie Sarvaas GJ, et al. Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD. Pediatrics. 2014;134(4):e1224-8. View abstract.
Waldman HS, Basham SA, Price FG, et al. Exogenous ketone salts do not improve cognitive responses after a high-intensity exercise protocol in healthy college-aged males. Appl Physiol Nutr Metab. 2018;43(7):711-7. View abstract.
Woods WG, Pawan GL, Semple SJ, Ralphs DN. Effect of intravenous 3-hydroxybutyrate on postoperative nitrogen balance. Hum Nutr Clin Nutr. 1983;37(5):391-4. View abstract.
Woolf EC, Syed N, Scheck AC. Tumor metabolism, the ketogenic diet and ß-hydroxybutyrate: novel approaches to adjuvant brain tumor therapy. Front Mol Neurosci. 2016;9:122. View abstract.